TOKYO — Japan’s Otsuka Pharmaceutical plans to roll out the world’s first commercial “digital pill” in the U.S. as early as next spring. The U.S. Food and Drug Administration in November green-lighted the drugmaker to produce and sell the product, Abilify MyCite.
Read more
Comments are closed.